RSS

Medicines and Healthcare products Regulatory Agency (MHRA)

In preparations for Brexit, the EMA has redistributed the UK’s product portfolio to other EU members and is not allocating any centralised marketing authorisation applications to the MHRA. We take a closer look… more

Opinion

The Association of the British Pharmaceutical Industry (ABPI) has responded to the recent publication of the Medicines and Healthcare products Regulatory Agency (MHRA) technical guidance on what the Brexit implementation means for life sciences. more

News

Some medicines containing valsartan used for the treatment of high blood pressure and heart conditions are being recalled across Europe to be reviewed by the European Medicines Agency (EMA) to determine the extent of ingredient impurity. more

News

Specialty pharmaceutical company, Alliance Pharma, has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the UK marketing authorisation application for Diclectin. more

News

‘Doing nothing is not an option’ is the overriding message from pharmaceutical experts who attended the recent Pharmaceutical Industry Network Group (PING) seminar, held in conjunction with Ethical Medicines Industry Group (EMIG). more

News

Specialty pharmaceutical company, Alliance Pharma, has revealed that following discussions with the MHRA and the CHM, the marketing authorisation application for Diclectin is now considered approvable. more

News

Virgin Atlantic Cargo has been granted a wholesale distribution authorisation (WDA) for its global headquarters operations and its new Pharma Zone at Heathrow Airport, which confirms the airline’s compliance with good distribution practice (GDP) more

News

The Medicines and Healthcare products Regulatory Agency (MHRA) has implemented changes to the licence for valproate medicines — Epilim, Depakote and generics used to treat epilepsy and bipolar disorder — in the interest of public safety. more

News

Recent analysis from the Medicines and Healthcare products Regulatory Agency (MHRA) has revealed that black market trading in top strength Diazepam (10 mg) has dropped by more than 60% more

News

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive opinion to Akcea Therapeutics’ volanesorsen for the treatment of familial chylomicronaemia syndrome (FCS) under the Early Access to Medicines Scheme (EAMS). more

News

A patient and a pharmacy level drug alert recall has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for three specific lots of asthma inhalers as they may not deliver the full number doses more

News

The Association of the British Pharmaceutical Industry (ABPI) has issued its reaction to the publication of the Medicines and Healthcare products Regulatory Agency’s (MHRA) update to pharma companies on preparing for Brexit. more

News

A new government ruling, allowing the erectile dysfunction (ED) drug Sildenafil to be sold without a prescription, could mean drug prices fall further. more

News

During the 12th Annual Lecture, organised by the Medicines and Healthcare products Regulatory Agency (MHRA), Dr Jeremy Farrar OBE, director of the Wellcome Trust, stressed the importance of safeguarding global health in politically uncertain times. more

News

Apparently so, says Professor Jeremy Farrar, head of the Wellcome Trust. more

Opinion

As the new academic year begins, the Medicines & Healthcare products Regulatory Agency (MHRA) is campaigning to students about the risks of self-prescribing and self-medicating with medicines purchased online. more

News

Antiepileptic drugs and the potentially harmful effects on unborn children has hit the headlines as a survey reveals many women have not received the new safety warnings about the dangers of taking it during pregnancy. more

News

A company-led product recall by Novo Nordisk has been announced for certain batches of its NovoPen Echo and NovoPen 5 products, according to a press release from the Medicines and Healthcare products Regulatory Agency (MHRA). more

Technology

During the BIA and MHRA conference Lord O'Shaughnessy (parliamentary under secretary of State for Health) has outlined the government's plans to support and promote the UK's life sciences sector post-Brexit. more

News

Santhera Pharmaceuticals has announced that the MHRA has granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) to Raxone (idebenone) for patients with respiratory function decline not taking glucocorticoids in DMD more

News